525 related articles for article (PubMed ID: 15451783)
21. Lp-PLA
Acosta S; Taimour S; Gottsäter A; Persson M; Engström G; Melander O; Zarrouk M; Nilsson PM; Smith JG
Atherosclerosis; 2017 Jul; 262():14-18. PubMed ID: 28475940
[TBL] [Abstract][Full Text] [Related]
22. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
23. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.
Khuseyinova N; Imhof A; Rothenbacher D; Trischler G; Kuelb S; Scharnagl H; Maerz W; Brenner H; Koenig W
Atherosclerosis; 2005 Sep; 182(1):181-8. PubMed ID: 16115490
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Sarno MJ; Bettencourt R; Wolfert RL; Barrett-Connor E
J Am Coll Cardiol; 2008 Mar; 51(9):913-9. PubMed ID: 18308160
[TBL] [Abstract][Full Text] [Related]
25. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
[TBL] [Abstract][Full Text] [Related]
26. Lp-PLA2: an emerging biomarker of coronary heart disease.
Dada N; Kim NW; Wolfert RL
Expert Rev Mol Diagn; 2002 Jan; 2(1):17-22. PubMed ID: 11963798
[TBL] [Abstract][Full Text] [Related]
27. Association between the serum lipoprotein-associated phospholipase A
Dong L; Tong J; Fan S
Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.
Kardys I; Oei HH; van der Meer IM; Hofman A; Breteler MM; Witteman JC
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):631-6. PubMed ID: 16373603
[TBL] [Abstract][Full Text] [Related]
29. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.
Iribarren C; Gross MD; Darbinian JA; Jacobs DR; Sidney S; Loria CM
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):216-21. PubMed ID: 15499045
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
[TBL] [Abstract][Full Text] [Related]
31. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
Koenig W; Löwel H; Baumert J; Meisinger C
Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
[TBL] [Abstract][Full Text] [Related]
34. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
35. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
36. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
[TBL] [Abstract][Full Text] [Related]
37. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
Tehrani DM; Gardin JM; Yanez D; Hirsch CH; Lloyd-Jones DM; Stein PK; Wong ND
Atherosclerosis; 2013 Dec; 231(2):246-51. PubMed ID: 24267235
[TBL] [Abstract][Full Text] [Related]
38. Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.
Wootton PT; Stephens JW; Hurel SJ; Durand H; Cooper J; Ninio E; Humphries SE; Talmud PJ
Atherosclerosis; 2006 Nov; 189(1):149-56. PubMed ID: 16438975
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
[TBL] [Abstract][Full Text] [Related]
40. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.
Schaefer EJ; McNamara JR; Asztalos BF; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
Am J Cardiol; 2005 May; 95(9):1025-32. PubMed ID: 15842965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
